NEW YORK (Reuters) - Leading global pharmaceutical companies have started to view their vast portfolios of older, established prescription drugs as vehicles for raising large sums of cash to fuel development of new medicines with far higher profit margins.

from Reuters: Business News http://ift.tt/1kynEe9
from Reuters: Business News http://ift.tt/1kynEe9
Tidak ada komentar:
Posting Komentar